Correction to: Potential therapeutic strategies for osteoarthritis via CRISPR/Cas9 mediated gene editing.

IF 6.9 2区医学 Q1 ENDOCRINOLOGY & METABOLISM

Reviews in Endocrine & Metabolic Disorders Pub Date : 2024-04-01 DOI:10.1007/s11154-023-09867-5

Rexhina Vlashi, Xingen Zhang, Haibo Li, Guiqian Chen

引用次数: 0

Abstract Image

查看原文本刊更多论文

更正：通过 CRISPR/Cas9 介导的基因编辑治疗骨关节炎的潜在策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Reviews in Endocrine & Metabolic Disorders 医学-内分泌学与代谢

CiteScore

14.70

自引率

1.20%

发文量

审稿时长

>12 weeks

期刊介绍： Reviews in Endocrine and Metabolic Disorders is an international journal dedicated to the field of endocrinology and metabolism. It aims to provide the latest advancements in this rapidly advancing field to students, clinicians, and researchers. Unlike other journals, each quarterly issue of this review journal focuses on a specific topic and features ten to twelve articles written by world leaders in the field. These articles provide brief overviews of the latest developments, offering insights into both the basic aspects of the disease and its clinical implications. This format allows individuals in all areas of the field, including students, academic clinicians, and practicing clinicians, to understand the disease process and apply their knowledge to their specific areas of interest. The journal also includes selected readings and other essential references to encourage further in-depth exploration of specific topics.